Coya Therapeutics, Inc. (COYA)
(Delayed Data from NSDQ)
$5.50 USD
-0.24 (-4.18%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $5.61 +0.11 (2.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Coya Therapeutics, Inc. has a market cap of $96.00M, which represents its share price of $5.74 multiplied by its outstanding shares number of 16.73M. As a small-cap company, COYA's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
COYA 5.50 -0.24(-4.18%)
Will COYA be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for COYA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for COYA
Coya Therapeutics, Inc. (COYA) Now Trades Above Golden Cross: Time to Buy?
Coya Therapeutics, Inc. (COYA) Reports Q2 Loss, Lags Revenue Estimates
COYA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Regenxbio (RGNX) Reports Q2 Loss, Lags Revenue Estimates
EyePoint Pharmaceuticals (EYPT) Reports Q2 Loss, Misses Revenue Estimates
Coya Therapeutics, Inc. (COYA) Surges 10.7%: Is This an Indication of Further Gains?
Other News for COYA
COYA forms 180 Bearish Setup on September 20
Is COYA ready to move higher? Stochastic Buy Signal shows up after rocketing 6.1%
Lower Bollinger Band Walk appears for COYA after 4.59% move
Coya Therapeutics, Inc. (COYA) Gets a Buy from Lake Street
COYA: Analyst Jason Kolbert Maintains 'Buy' Rating with $18 Target | COYA Stock News